EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.1.97 | drug development | NMT is a putative drug target | Trypanosoma brucei |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.97 | additional information | knockdown of NMT expression by tetracycline-inducible RNA interference leads to cell death with a block in endocytosis, but vesicle accumulation around the flagellar pocket indicates a defect in vesicular progression following endocytic fusion. Induced parasites have a wild-type or slightly enlarged Golgi apparatus, phenotype and pleiotropic effects, overview | Trypanosoma brucei |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.97 | additional information | Trypanosoma brucei | presence of approximately 60 putative N-myristoylated proteins encoded by the Trypanosoma brucei genome | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.97 | Trypanosoma brucei | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.97 | additional information | presence of approximately 60 putative N-myristoylated proteins encoded by the Trypanosoma brucei genome | Trypanosoma brucei | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.97 | myristoyl-CoA:protein N-myristoyltransferase | - |
Trypanosoma brucei |
2.3.1.97 | NMT | - |
Trypanosoma brucei |